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Methods: We	conducted	a	 systematic	 literature	 search	 in	PubMed,	PsycINFO,	
CINAHL	 and	 EMBASE	 for	 observational,	 longitudinal	 studies	 published	 from	
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1 	 | 	 INTRODUCTION
Depression	and	diabetes	mellitus	are	among	the	 leading	
causes	of	disability	worldwide.	The	most	recent	estimates,	
available	 for	 2017,	 suggest	 worldwide	 264  million	 peo-
ple	living	with	depression	and	476 million	with	diabetes;	










ence	 of	 diabetes	 has	 been	 linked	 to	 an	 increased	 risk	 of	
incident	diabetes	complications	such	as	retinopathy,	neu-


































•	 The	 association	 between	 depression	 and	 dia-
betes	 has	 been	 suggested	 to	 be	 bidirectional.	
A	possible	mechanism	 linking	depression	and	
diabetes	 are	 suboptimal	 HbA1c	 levels.	 Prior	
studies	 regarding	 the	 association	 between	 de-
pression	and	HbA1c	levels	showed	mixed	results	
and	have	not	been	systematically	summarised.
•	 The	 present	 meta-	analysis	 suggests	 a	 bidirec-
tional	 longitudinal	 association	 between	 de-
pressive	symptoms	and	HbA1c.	Due	to	the	low	
number	of	eligible	studies,	 further	research	 in	
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A	 possible	 mechanism	 linking	 depression	 to	 these	 ad-






consistent	 findings	 and	 faced	 methodological	 limitations.	






















In	 summary,	 prior	 evidence	 regarding	 depression	 as	
a	 risk	 factor	 for	 suboptimal	HbA1c	 levels	 revealed	mixed	
findings,	is	mainly	based	on	cross-	sectional	data	and	needs	
updating,	 whereas	 the	 evidence	 regarding	 suboptimal	
HbA1c	levels	as	a	risk	factor	for	depression	needs	increased	
power	 to	 assess	 the	 association	 of	 early	 hyperglycaemia	
with	depression.	Further,	there	is	a	need	to	assess	whether	
the	association	is	truly	bidirectional	which	requires	(large	







2 	 | 	 METHODS
2.1	 |	 Search strategy
We	 performed	 a	 systematic	 literature	 search	 in	 the	 fol-
lowing	databases:	PubMed,	PsycINFO	(Ebsco),	CINAHL	
(Ebsco)	and	EMBASE	(OVID).	Searches	were	conducted	
for	 studies	 indexed	 between	 January	 1,	 2000	 to	 July	 29,	
2019	 and	 were	 updated	 until	 September	 30,	 2020.	 We	
restricted	 to	articles	written	 in	English,	Dutch,	German,	
Spanish	or	French.	Studies	published	before	January	2000	
were	 not	 included	 due	 to	 the	 previous	 meta-	analysis	 by	
Lustman	et	al.	including	studies	up	until	that	date.13
This	 review	 is	 registered	 with	 the	 International	
Prospective	Register	of	Systematic	Reviews	(PROSPERO;	
registration	number:	CRD42019147551)	and	is	performed	
in	 accordance	 with	 the	 MOOSE	 guidelines15	 and	 the	





2.2	 |	 Selection criteria
Two	 pairs	 of	 reviewers	 (MB	 and	 MS,	 RM	 and	 AG)	 in-
dependently	 screened	 the	 titles	 and	 abstracts	 retrieved.	
Subsequently,	 full-	text	 screening	 was	 performed	 in	 par-
allel	by	MB	and	RM	based	on	predefined	 in-	and	exclu-
sion	 criteria	 (Table  S2).	 Any	 disagreement	 was	 resolved	
by	 consulting	 a	 third	 reviewer.	 Additionally,	 we	 hand-	
searched	 reference	 lists	 of	 papers	 eligible	 for	 inclusion.	
The	core	criteria	for	inclusion	were	a	prospective	cohort	
study	 design	 with	 two	 or	 more	 measurements,	 a	 study	
sample	size	of	>50	participants,	and	an	adult	(≥18 years)	











controlled	 trials	 and	 other	 intervention	 studies	 were	 ex-
cluded	 because	 they	 would	 answer	 a	 different	 research	
question	and	require	different	methodology.
2.3	 |	 Data extraction
We	 pilot	 tested	 the	 data	 extraction	 form	 independently	
(MB	and	RM)	using	six	studies	to	minimise	bias	and	er-
rors.	 As	 the	 extractions	 were	 highly	 comparable,	 one	
reviewer	 (MB)	 completed	 the	 data	 extraction.	 AG	 ex-
tracted	 the	 data	 from	 the	 new	 studies	 identified	 during	
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the	repeated	search.	The	 following	characteristics	of	 the	
included	studies	were	extracted:	Authors,	year	of	publica-
tion,	 country,	 age,	 sex,	 detailed	 description	 of	 the	 study	
population,	 sample	 size,	 assessment	 method	 for	 depres-
sion,	 diabetes	 type,	 assessment	 method	 for	 HbA1c,	 use	






2.4	 |	 Quality assessment
The	 quality	 of	 the	 included	 studies	 was	 assessed	 by	 use	
of	 the	 Newcastle-	Ottawa-	Scale	 (NOS)	 which	 examines	
three	 domains:	 selection,	 comparability	 and	 outcome.	
The	slightly	adjusted	version	of	 the	NOS	including	a	ra-
tionale	 for	 adjustments	 can	 be	 found	 in	 the	 Supporting	
Information.	One	reviewer	(MB)	conducted	the	quality	as-
sessment	which	was	independently	assessed	by	a	second	
reviewer	 for	30%	of	 the	 included	articles	 (RM).	 In	order	
to	 judge	 the	overall	quality	of	a	study,	 results	were	con-
verted	to	the	Agency	for	Healthcare	Research	and	Quality	
Standards	(see	Supporting	Information–	Methods).
2.5	 |	 Statistical analysis
All	statistical	analyses	were	conducted	in	R	by	use	of	the	




adjusted	 effect	 estimate	 were	 presented	 in	 the	 article,	
the	 adjusted	 effect	 estimate	 was	 chosen,	 as	 advised	 by	
the	 COSMOS-	E	 guidelines.18	 In	 order	 to	 enable	 pooling	
of	 the	 results,	 regression	 coefficients	 were	 transformed	
into	partial	correlation	coefficients	(rp).
19,20	Fisher's	r-	to-	z	






played	 in	 forest	 plots.	 We	 assessed	 heterogeneity	 using	
I²	statistics	(low	(25%),	moderate	(50%),	high	(75%))	and	
determined	the	risk	of	publication	bias	by	visual	 inspec-
tion	 of	 funnel	 plots.	 We	 explored	 heterogeneity	 and	 the	
robustness	of	our	results	by	iteratively	removing	one	study	
to	assess	each	study's	influence	on	the	pooled	estimate	for	
both	 outcomes.	 We	 also	 intended	 conducting	 sensitivity	
analyses	such	as	comparing	studies	with	different	types	of	
depression	assessment	and	exploring	heterogeneity	using	
meta-	regression.	 However,	 the	 limited	 number	 of	 avail-
able	studies	did	not	allow	for	such	exploration.
3 	 | 	 RESULTS











the	 longitudinal	 association	 between	 depressive	 symp-
toms	and	HbA1c
24,37-	41	and	five	assessed	the	longitudinal	




depressive	 symptoms	 and	 HbA1c	 as	 an	 outcome	 due	 to	

















3.2	 |	 Quality assessment
For	studies	with	HbA1c	as	the	outcome	variable,	we	rated	
thirteen	 as	 having	 good	 quality,	 one	 as	 fair	 and	 five	 as	
having	 poor	 quality	 according	 to	 NOS.	 Inter-	rater	 reli-
ability	for	quality	assessment	was	0.79	(Gwet's	Agreement	
Coefficient	 1).	 For	 studies	 with	 depression	 as	 outcome	
variable,	 eight	 were	 evaluated	 as	 good,	 one	 as	 fair	 and	










3.3	 |	 Longitudinal association of 
depressive symptoms with HbA1c
Six	studies	 that	 investigated	 the	 longitudinal	association	
of	depressive	symptoms	with	HbA1c	with	a	combined	sam-
ple	 size	 of	 3,683	 individuals	 were	 included	 in	 the	 meta-	
analysis.	The	 follow-	up	periods	 ranged	 from	six	months	
to	five	years	with	a	mean	follow-	up	period	of	37 months.	
Results	 showed	 a	 small	 significant	 association	 between	
depressive	 symptoms	 (at	 baseline)	 and	 HbA1c	 levels	
(at	 follow-	up)	 (rp = 0.07;	 [95%	CI	0.03,	0.12],	p = 0.002;	
Figure 2).	Between-	study	heterogeneity	was	 found	 to	be	




Thirteen	 studies	 with	 HbA1c	 as	 an	 outcome	 could	 not	
be	included	in	the	meta-	analysis	due	to	the	reported	effect	




teen	 studies,	 five	 reported	 that	major	depressive	disorder/





3.4	 |	 Longitudinal association of 
HbA1c with major depressive disorder/
depressive symptoms
Five	 studies	 that	 investigated	 the	 longitudinal	 associa-
tion	of	HbA1c	with	major	depressive	disorder/depressive	
F I G U R E  1  Flowchart	of	the	study	selection	process
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symptoms	 with	 a	 combined	 sample	 size	 of	 45,110	 indi-
viduals	 were	 included	 in	 the	 meta-	analysis.	 The	 follow-
	up	 periods	 ranged	 from	 six	 months	 to	 three	 years	 with	









Seven	 studies	 could	 not	 be	 included	 in	 the	 meta-	
analyses	due	to	the	reported	effect	measures	(e.g.	results	
presented	 for	 quintiles	 of	 HbA1c).	 Of	 these,	 three	 found	
that	higher	HbA1c	levels	were	associated	with	an	increased	
risk	 for	 subsequent	 (probable)	 depression23,26,31;	 four	 re-
ported	no	significant	association.22,35,37,38 The	results	and	
reasons	for	exclusion	are	presented	in	detail	in	Table S6.
4 	 | 	 DISCUSSION
In	this	meta-	analysis	and	systematic	review,	we	extensively	





support	 the	 temporality	of	both	associations.	Due	 to	 the	
methodological	 issues	 observed	 in	 meta-	analysing	 data	
from	the	available	 literature,	we	consider	 this	work	as	a	
first	 step	 in	 exploring	 the	 longitudinal	 and	 bidirectional	
association	between	depression	and	HbA1c	levels.
4.1	 |	 Longitudinal association of 
depressive symptoms with HbA1c
We	 found	 a	 small,	 but	 significant	 association	 between	
depressive	 symptoms	 and	 HbA1c	 levels	 at	 follow-	up	 as	
an	outcome	 in	our	meta-	analysis.	 Importantly,	 these	 re-
sults	 suggest	 temporality	 of	 this	 association.	 Our	 find-
ing	 extends	 previous	 research	 on	 cross-	sectional	 studies	
by	 Lustman	 and	 colleagues	 where	 the	 authors	 found	 a	
small-	to-	moderate	 significant	 association.13	 A	 possible	
explanation	for	the	somewhat	reduced	magnitude	of	the	
effect	could	be	that	longitudinal	studies	are	often	subject	
to	 attrition	 bias	 with	 healthier	 individuals	 less	 likely	 to	
drop-	out,	leading	to	an	underestimation	of	the	effect	size.	
















ment	 of	 hyperglycaemia	 could	 be	 via	 behavioural	 medi-
ation.	Higher	depressive	symptoms	have	been	associated	
with	less	optimal	diabetes	self-	management	which	has	in	
turn	 been	 related	 to	 hyperglycaemia.48	 A	 meta-	analysis	
found	 a	 moderate	 association	 between	 depression	 and	
reduced	diabetes	self-	management	with	the	strongest	as-








viduals	 on	 antidepressant	 treatment	 compared	 to	 those	
without.S53
Since	 associations	 with	 depressive	 symptoms	 were	











on	 a	 mediation	 analysis,	 Schmitz	 et	 al.	 suggested	 that	




4.2	 |	 Longitudinal association of HbA1c 
with depression
Our	meta-	analysis	on	the	association	between	HbA1c	and	
depression	 as	 an	 outcome	 yielded	 a	 significant	 associa-
tion	between	higher	HbA1c	and	higher	risk	for	(probable)	
depression.	This	finding	contradicts	results	from	a	previ-
ous	 meta-	analysis,14	 which	 concluded	 that	 hyperglycae-
mia	 or	 hyperinsulinemia	 is	 unlikely	 to	 be	 related	 to	 the	
development	of	depression.	However,	 this	 study	did	not	
investigate	 a	 linear	 contribution	 of	 HbA1c	 to	 the	 inci-








our	 findings.	 Studies	 which	 found	 an	 association	 had	 a	












cies,	 and	 cause	 the	 generation	 of	 advanced	 glycation	




mia	might	 lead	to	 increased	cortisol	 levels,S54	which	has	
been	 associated	 with	 incident	 depression.S56	 Other	 po-
tential	 mechanisms	 include	 low-	grade	 inflammation,S57	
reductions	in	serum	brain-	derived	neurotrophic	factorS57	
or	vascular	damage	in	brain	regions	 implicated	in	mood	







Importantly,	 both	 HbA1c	 levels	 and	 depression	 have	
been	linked	to	diabetes	distress.S59	Diabetes	distress	refers	
to	 negative	 behavioural	 and	 emotional	 reactions	 due	 to	
suffering	from	diabetes.	It	can	be	induced	by	the	diagnosis	
itself,	 fear	 or	 experience	 of	 complications,	 struggle	 with	
self-	management	or	other	factors	that	are	specific	 to	the	
















tress	 was	 associated	 with	 HbA1c	 levels	 cross-	sectionally	
and	in	the	time-	varying	analysis	but	not	in	the	prospective	




4.3	 |	 Limitations and strengths
The	quality	of	our	meta-	analyses	is	highly	dependent	on	
the	 quality	 of	 available	 literature.	 We	 only	 found	 a	 few	
studies	 that	 have	 investigated	 the	 association	 between	
depression	and	HbA1c	and	vice	versa.	Based	on	 the	 lim-
ited	number	of	studies,	we	could	not	formally	assess	pub-









comparing	 users	 and	 non-	users	 of	 insulin,	 potential	 dif-
ferences	were	only	analysed	in	the	study	by	Aikens	et	al.	
The	results	suggested	that	HbA1c	is	only	associated	with	
depressive	 symptoms	 among	 insulin-	users	 compared	 to	
individuals	on	oral	medication	alone.37
Moreover,	 most	 studies	 in	 the	 meta-	analysis	 assessed	
depression	 by	 use	 of	 a	 self-	report	 questionnaire.	 Self-	
report	 questionnaires	 are	 widely	 used	 in	 research	 to	 as-
sess	‘depression’	because	clinical	diagnoses	are	often	not	
available.S59	 Although	 cut-	off	 scores	 on	 self-	report	 ques-









on	 a	 comprehensive	 search	 including	 four	 databases,	
addressing	 both	 directions	 of	 the	 association	 between	
depression	 and	 HbA1c.	 Moreover,	 searches	 included	 pa-
pers	 in	Dutch,	German,	Spanish,	and	French	aside	from	








Furthermore,	 despite	 the	 dissent	 in	 the	 current	 liter-
ature	 on	 how	 to	 best	 pool	 regression	 coefficients	 (e.g.	
S65–	68)	and	the	lack	of	information	on	converting	effect	








4.4	 |	 Recommendations and future 
perspectives
The	 results	 of	 our	 systematic	 review	 and	 meta-	analysis	
support	 a	 bidirectional	 association	 between	 depression/
depressive	 symptoms	 and	 HbA1c.	 Further	 research	 is	




nal	 studies	 on	 the	 bidirectional	 association	 between	 de-
pression	and	HbA1c	are	firstly	needed.














in	 individuals	 with	 type	 1	 diabetes	 to	 allow	 for	 compar-
ison	 between	 these	 important	 subgroups.	 Furthermore,	
assessment	 of	 type	 of	 diabetes	 treatment	 and	 stratified	
analyses	based	on	insulin-	use	are	recommended.	Another	
subject	 that	 requires	 attention	 is	 the	 long-	term	 effect	 of	
high	glucose	 levels	on	depression.	Based	on	our	system-
atic	 search,	we	conclude	 that	 there	 is	a	need	 for	 studies	
assessing	the	impact	of	high	HbA1c	levels	on	depression	at	
multiple	time	points	over	a	longer	follow-	up	period.	Aside	





A	 bidirectional	 association	 between	 depression	 and	
HbA1c	 levels	 may	 also	 have	 important	 clinical	 implica-
tions.	Routine	 screening	 for	depressive	 symptoms	by	di-
abetes	health	care	 teams	 is	recommended	 in	 individuals	
with	 all	 types	 of	 diabetes.	 Special	 attention	 needs	 to	 be	
paid	to	ensure	that,	if	symptom	scores	indicate	the	pres-
ence	of	depressive	symptoms,	affected	individuals	actually	




depressive	 disorder,	 is	 particularly	 important	 to	 avoid	




comprehensive	 overview	 of	 interventions	 for	 depression	
and	diabetes,	Petrak	et	al.	highlight	 the	need	to	conduct	
active	comparison	studies	that	elucidate	the	effectiveness	
of	 individual	 intervention	 components.S75  Moreover,	 de-





5 	 | 	 CONCLUSION
This	meta-	analysis	suggests	that	depressive	symptoms	are	
associated	with	an	 increased	risk	 for	 the	development	of	
higher	 HbA1c	 levels	 over	 time	 and	 that	 HbA1c	 levels	 are	





research	 in	 large-	scale	 longitudinal	 studies	 is	 needed	 to	
confirm	this	association.	Future	studies	should	investigate	




this	 endeavour.	 In	 relation	 to	 clinical	 practice,	 the	 find-
ings	 suggest	 that	 depression	 and	 HbA1c	 levels	 should	 be	
targeted	concurrently	by	prevention	and	treatment	efforts.
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